Alex Nemiroff
Fortuna: 9 M $ al 31/05/2026
Fortuna: 9 M $ al 31/05/2026
Alex Nemiroff is the founder of RogCon, Inc., established in 2015, holding the title of Chief Executive Officer.
Mr. Nemiroff is the founder of RogCon U.R., Inc., established in 2015, holding the title of Chief Executive Officer.
Mr. Nemiroff currently works at Praxis Precision Medicines, Inc. as Secretary & General Counsel since 2020.
Mr. Nemiroff completed undergraduate education at Stephen M.
Ross School of Business and graduate education at Northwestern University School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/05/2026 | 26.011 ( 0,09 % ) | 9 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Consejero General | 01/01/2020 |
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on drug research, discovery and development | Director Ejecutivo | 01/11/2015 |
RogCon U.R., Inc. | Director Ejecutivo | 01/11/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University School of Law
Northwestern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on drug research, discovery and development | Health Technology |
RogCon U.R., Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.